The Relative Strength (RS) Rating for Elanco Animal Health jumped into a new percentile Wednesday, with an increase from 68 to 82.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the top-performing stocks typically have an 80 or better RS Rating as they launch their biggest climbs.
While now is not an ideal time to jump in, see if the stock is able to form a base and break out.
Elanco Animal Health reported 9% earnings growth in the latest quarterly report, while sales growth came in at -1%.
The company holds the No. 1 rank among its peers in the Medical-Supplies industry group. Henry Schein and Avanos Medical are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
